Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can we predict mesh infections before they happen? a new study aims to find out

NCT ID NCT07725718

Knowledge-focused Sponsor: Minia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Aug 19, 2026 · Updated 2 times

Summary

This study follows 420 adults undergoing abdominal wall reconstruction with mesh to identify which patient, surgical, and recovery factors most strongly predict a mesh infection within 90 days. Researchers will track 18 potential risk factors and use statistical analysis to pinpoint the independent contributors. The goal is to help surgeons better assess risk, tailor surgical choices, and improve shared decision-making with patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help surgeons identify high-risk patients before surgery and choose safer techniques or materials to prevent mesh infections.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 420 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive adults (≥18 years) undergoing elective or urgent abdominal wall reconstruction with synthetic, biosynthetic or biological mesh for a ventral, incisional, parastomal or complex abdominal wall defect at a single tertiary referral hernia and abdominal wall surgery unit.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 years. * Undergoing elective or urgent abdominal wall reconstruction with implantation of synthetic, biosynthetic or biological mesh for a ventral, incisional, parastomal or complex abdominal wall defect. * Able and willing to provide written informed consent and to attend scheduled follow-up. Exclusion Criteria: * Suture-only repair without mesh. * Inguinal or femoral (groin) hernia repair. * Active systemic sepsis or established intra-abdominal mesh infection at the time of index surgery. * Mesh placed solely for a non-reconstructive indication (e.g. temporary abdominal closure or planned re-look without definitive reconstruction). * Estimated life expectancy \< 12 months or inability to complete the minimum follow-up. * Patient declines participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal wall defect are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal wall malformation Hernia, Ventral Incisional Hernia prosthesis-related infectious disease Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal wall defect Incisional hernia Parastomal hernia Prosthesis-related infections (mesh infection) Surgical wound infection Ventral hernia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Minia University Hospitals - Department of Surgery, Faculty of Medicine, Minia University

    RECRUITING

    Minya, Minya Governorate, 61519, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.